Literature DB >> 8258989

Regulation of granulocytosis in inflammatory disease and in leukemia.

P Reizenstein, L Stenke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8258989     DOI： 10.1007/bf02987761

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN： 0736-0118


× No keyword cloud information.
  27 in total

1.  Low-dose Ara-C plus granulocyte/macrophage colony-stimulating factor for the treatment of myelodysplastic syndromes. EORTC Leukemia Group.

Authors:  H H Gerhartz; G Visani; A Delmer; H Zwierzina; M Ribeiro; A Jacobs; R Marcus; M Baumelou; D Fière; B Labar
Journal:  Bone Marrow Transplant       Date:  1989-12       Impact factor: 5.483

2.  Elevated white blood cell synthesis of leukotriene C4 in chronic myelogenous leukaemia but not in polycythaemia vera.

Authors:  L Stenke; J Samuelsson; J Palmblad; L Dabrowski; P Reizenstein; J A Lindgren
Journal:  Br J Haematol       Date:  1990-03       Impact factor: 6.998

3.  Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease.

Authors:  K M Taylor; S Jagannath; G Spitzer; J A Spinolo; S L Tucker; B Fogel; F F Cabanillas; F B Hagemeister; L M Souza
Journal:  J Clin Oncol       Date:  1989-12       Impact factor: 44.544

4.  Granulocyte colony-stimulating factor stimulates recovery of granulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation.

Authors:  J Neidhart; A Mangalik; W Kohler; C Stidley; J Saiki; P Duncan; L Souza; M Downing
Journal:  J Clin Oncol       Date:  1989-11       Impact factor: 44.544

5.  Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver--conditioned medium.

Authors:  K M Zsebo; J Wypych; I K McNiece; H S Lu; K A Smith; S B Karkare; R K Sachdev; V N Yuschenkoff; N C Birkett; L R Williams
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

6.  Effects of prolonged treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor.

Authors:  P Greenberg; R Negrin; A Nagler; M Vincent; T Donlon
Journal:  Int J Cell Cloning       Date:  1990-01

7.  Dissociation of the proliferation and differentiation stimuli of granulocyte colony-stimulating factor (G-CSF).

Authors:  A E Irvine; J J Berney; G E Francis
Journal:  Leukemia       Date:  1990-03       Impact factor: 11.528

8.  Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy.

Authors:  F Herrmann; G Schulz; M Wieser; K Kolbe; U Nicolay; M Noack; A Lindemann; R Mertelsmann
Journal:  Am J Med       Date:  1990-06       Impact factor: 4.965

9.  Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome with excess blasts.

Authors:  F Herrmann; A Lindemann; H Klein; M Lübbert; G Schulz; R Mertelsmann
Journal:  Leukemia       Date:  1989-05       Impact factor: 11.528

10.  Synthesis of granulocyte colony-stimulating factor and its requirement for terminal divisions in chronic myelogenous leukemia.

Authors:  H Klein; R Becher; M Lübbert; W Oster; E Schleiermacher; M A Brach; L Souza; A Lindemann; R H Mertelsmann; F Herrmann
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.